These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 12520749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of combined chemotherapy including high-dose cisplatin in the treatment of malignant tumors].
    Zhou JC, Feng FY, Sun Y, Wang QL, Zeng WY, Liu YY.
    Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):136-9. PubMed ID: 2820683
    [Abstract] [Full Text] [Related]

  • 9. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
    Lena MD, Ramlau R, Hansen O, Lorusso V, Wagner L, Barni S, Cristovao MM, Huber R, Alberola V, Mitrovic M, Colin C, Gasmi J.
    Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
    [Abstract] [Full Text] [Related]

  • 10. [Comparative study of three different chemotherapy protocols for advanced non-small-cell lung cancer].
    Chen L, Wang J, Chu X.
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):151-2. PubMed ID: 11776862
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer.
    Chen CH, Lin CM, Kao KC, Chang JW, Tsao TC.
    Chang Gung Med J; 2007 Mar; 30(3):249-55. PubMed ID: 17760276
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D, Golubicic I, Gavrilovic D, Kezic I, Jelic S.
    J BUON; 2009 Mar; 14(2):203-9. PubMed ID: 19650167
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P, Petruzelka L, Zemanova M, Havel L, Janku F, Judas L, Kubik A, Krepela E, Fiala P, Pecen L.
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A randomized trial with various combinations of cis-platinum (CDDP), mitomycin C (MMC), peplomycin (PEP) and ftorafur (FT) in the treatment of non-small cell lung cancer].
    Nakabayashi T, Yasuda S, Miyamoto H, Abe S, Ohosaki Y.
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2998-3004. PubMed ID: 2429619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.